全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 461432-24-6 | Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucopyranoside | C22H27ClO7 |
| 461432-25-7 | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate;[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate | C29H33ClO10 |
| 461432-26-8 | Dapagliflozin;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol | C21H25ClO6 |
| 461640-33-5 | N2-Acetyl-L-lysyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-phenylalanyl-L-phenylalaninamide | C39H59N7O6 |
| 461642-78-4 | 2-[Dodecylthio(thiocarbonyl)thio]-2-methylpropionic acid;S-1-Dodecyl S'-(alpha,alpha-dimethylacetic acid) trithiocarbonate; S-1-Dodecyl-S'-(alpha,alpha'-dimethyl-alpha''-acetic acid)trithiocarbonate | C17H32O2S3 |
| 461648-39-5 | (1-Azabicyclo[2.2.2]oct-4-yl)(diphenyl)methanol | C20H23NO |
| 462100-06-7 | 5,8,11-Trioxa-2-azatridecanedioic acid 1-(1,1-dimethylethyl) ester | C13H25NO7 |
| 462128-39-8 | 9,9-Diphenyl-9H-fluoren-2-ylboronic acid pinacol ester;2-(9,9-Diphenyl-9H-fluoren-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C31H29BO2 |
| 463303-91-5 | 5,6-Dihydro-spiro[7H-cyclopenta[c]pyridine-7,2'-pyrrolidine] | C11H14N2 |
| 463303-98-2 | 3-Bromo-4-pyridinepropanoic acid ethyl ester | C10H12BrNO2 |
| 463336-87-0 | 2-Bromo-6-isopropoxypyridine | C8H10BrNO |
| 463930-53-2 | N-(11-Bromoundecyl)carbamic acid tert-butyl ester | C16H32BrNO2 |
| 463962-58-5 | 1-O-[(3R,5R)-7-{2-(4-Fluorophenyl)-4-[(Z)-hydroxy(phenylimino)methyl]-5-isopropyl-3-phenyl-1H-pyrrol-1-yl}-3,5-dihydroxyheptanoyl]-β-D-glucopyranuronic acid;(3R,6R)-6-[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | C39H43FN2O11 |
| 463976-21-8 | 2-Iodo-4-trifluoromethylphenol;4-Trifluoromethyl-6-iodophenol; alpha,alpha,alpha-Trifluoro-o-iodo-p-cresol | C7H4F3IO |
| 464192-28-7 | 2-Bromo-5-fomylthiazole | C4H2BrNOS |
| 464193-92-8 | Fmoc-trans-4-hydroxy-D-proline tert-butyl ester;Fmoc-D-Hyp(tbu)-OH; N-(9-Fluorenylmethoxycarbonyl)-trans-4-hydroxy-D-proline tert-butyl ester | C24H27NO5 |
| 464213-10-3 | Ibipinabant;(4S)-3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide | C23H20Cl2N4O2S |
| 464913-11-9 | 3-Amino-2-hydroxy-N,N-dimethylbenzamide | C9H12N2O2 |
| 464916-25-4 | 1-(2-Ethoxy-2-oxoethyl)-3-methyl-1H-imidazolium chloride | C8H13N2O2.Cl |
| 464917-79-1 | (2Z)-3-Amino-2-butenoic acid phenylmethyl ester | C11H13NO2 |
| 464927-05-7 | 2,4-Dichloro-6-quinazolinol | C8H4Cl2N2O |
| 464927-84-2 | N,N-Diethyl-N-methyl-N-(2-methoxyethyl)ammonium bis(trifluoromethanesulfonyl)imide | C8H20NO.C2F6NO4S2 |
| 464930-76-5 | Boc-3-Methyl-L-beta-phenylalanine;Boc-(R)-3-Amino-3-(3-methylphenyl)propionic acid | C15H21NO4 |
| 465500-97-4 | 2,4-Dimethyl-D-phenylalanine;D-2,4-Dimethylphenylalanine | C11H15NO2 |
| 465514-09-4 | 2-Morpholinopyridine-3-carboxaldehyde;2-Morpholinonicotinaldehyde; 2-(Morpholin-4-yl)nicotinaldehyde | C10H12N2O2 |
| 465514-27-6 | 4-(1H-Pyrrol-1-yl)benzylamine;[4-(1H-Pyrrol-1-yl)phenyl]methanamine | C11H12N2 |
| 465514-33-4 | 2-(4-Morpholinyl)benzenemethanol;(2-Morpholinophenyl)methanol; [2-(Morpholin-4-yl)phenyl]methanol | C11H15NO2 |
| 465515-31-5 | 5-Carboxythiophene-2-boronic acid;2-Carboxythiophene-5-boronic acid; 5-Boronothiophene-2-carboxylic acid; 5-(Dihydroxyboryl)-2-thiophenecarboxylic acid | C5H5BO4S |
| 465529-56-0 | 5-Bromo-2-methyl-2H-indazole | C8H7BrN2 |
| 465529-57-1 | 5-Bromo-1-methyl-1H-indazole | C8H7BrN2 |
| 466639-53-2 | 3-Bromo-4-iodoanisole;2-Bromo-1-iodo-4-methoxybenzene | C7H6BrIO |
| 466678-44-4 | Lactosyl Pregabalin Pyrrolidone;(4S)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-4-(2-methylpropyl)pyrrolidin-2-one | C20H35NO11 |
| 467214-20-6 | Alvespimycin;17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin; 17-DMAG | C32H48N4O8 |
| 467214-21-7 | Alvespimycin hydrochloride;17-DMAG hydrochloride; BMS 826476; KOS 1022; 17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin hydrochloride | C32H48N4O8.HCl |
| 467214-46-6 | 6-Chloro-1H-indol-3-yl alpha-D-glucopyranoside | C14H16ClNO6 |
| 467220-49-1 | 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (1,4-naphthoquinone)palladium dimer | C62H60N4O4Pd2 |
| 467223-90-1 | 3,5-Difluorobenzeneethanol | C8H8F2O |
| 467435-07-0 | 4-Bromo-2-chlorobenzotrifluoride | C7H3BrClF3 |
| 467435-58-1 | 32,35-Bis[2-[(2,4-diethylheptyl)oxy]ethoxy]-6,7,9,10,12,13,15,16,18,19-decahydro-31H-4,21-(methano[1,3]benzenomethano)-26,30-metheno-25H-dibenzo[q,z][1,4,7,10,13,16]hexaoxacycloheptacosin | C64H94O10 |
| 467442-12-2 | 3,5-Difluoro-4-formylbenzoic acid 1,1-dimethylethyl ester | C12H12F2O3 |
| 467442-15-5 | 4-Cyano-2,6-difluorobenzaldehyde;3,5-Difluoro-4-formylbenzonitrile | C8H3F2NO |
| 467442-20-2 | (S)-2-(tert-Butoxycarbonylamino)-4,4-difluorobutanoic acid | C9H15F2NO4 |
| 467451-91-8 | 6-Trifluoromethoxy-1H-indole | C9H6F3NO |
| 467458-02-2 | N-[2-(6-Fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine monohydrochloride | C20H19F5N2O.HCl |
| 467458-46-4 | 3-Formyl-1H-indole-5-carboxylic acid ethyl ester;3-Formyl-5-ethoxycarbonyl-1H-indole | C12H11NO3 |
| 467459-31-0 | N-[2-(6-Fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine;Lu AE 58054 | C20H19F5N2O |
| 468075-00-5 | 2-Bromo-1-chloro-4-(trifluoromethoxy)benzene | C7H3BrClF3O |
| 468718-16-3 | 5-(Trifluoromethyl)-1H-indole-3-carboxaldehyde | C10H6F3NO |
| 468718-30-1 | 5-Cyano-2-fluorophenylboronic acid;5-Cyano-2-fluorobenzeneboronic acid | C7H5BFNO2 |
| 468740-43-4 | BMS-536924;Insulin-like Growth Factor-1 Receptor Inhibitor; 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone | C25H26ClN5O3 |